^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
AmoyDx® Essential NGS Panel

Type:
CE Marked
Related tests:

Details

Evidence
AmoyDx® Essential NGS Panel (Reversible Terminator Sequencing), based on Next Generation Sequencing (NGS) technology, is intended for qualitative detection of SNVs, InDels and Fusions in 10 driver genes in DNA extracted from formalin-fixed paraffin-embedded (FFPE) tissue or plasma sample in patients with NSCLC or CRC by converting sample nucleic acids to sequenceable libraries.
Cancer:
Colorectal Cancer, Non Small Cell Lung Cancer
Gene:
ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), HER-2 (Human epidermal growth factor receptor 2), KRAS (KRAS proto-oncogene GTPase), MET (MET proto-oncogene, receptor tyrosine kinase)
See More ...
Method:
Next-Generation Sequencing (NGS)